CreditReports.dk
HomeScreen companies

Hemab ApS Financials, key figures and credit report

CVR number: 40837590 Established 2019 Industry: 21 Manufacture of basic pharmaceutical products and pharmaceutical preparations
Company contact details
Nordre Fasanvej 215, 2000 Frederiksberg
Gross profit — FY 2025
EBIT -68 768.0 kUSD FY 2025 -40.2% vs 2024
Net debt - 185 485.0 kUSD FY 2025 -110.2% vs 2024
Quick ratio 18.2 FY 2025 +4 vs 2024

Income statement (kUSD)

2022
2023
2024
2025
Fiscal period length12121212
Net sales
Gross profit
Costs of management-2 238.00-4 852.00-7 501.00-9 259.00
Other operating expenses-19 420.00-23 807.00-41 566.00-59 509.00
EBIT-21 658.00-28 659.00-49 067.00-68 768.00
Other financial income5 216.002 467.006 597.00
Other financial expenses- 256.00- 135.00-2 197.00- 209.00
Pre-tax profit-21 914.00-23 578.00-48 797.00-62 380.00
Income taxes676.00795.00585.001 027.00
Net earnings-21 238.00-22 783.00-48 212.00-61 353.00

Assets (kUSD)

2022
2023
2024
2025
Intangible assets total
Machinery and equipment11.00259.00619.00421.00
Advance payments and construction in progress172.00101.00
Other tangible assets370.002 515.001 859.00
Tangible assets total183.00730.003 134.002 280.00
Investments total243.00476.00531.00
Long term receivables total
Inventories total
Current amounts owed by group member comp.513.00
Prepayments and accrued income195.002 516.003 617.004 439.00
Current other receivables258.001 190.00815.001 546.00
Current deferred tax assets736.00815.00605.001 082.00
Short term receivables total1 189.005 034.005 037.007 067.00
Other current investments76 423.0013 918.0097 511.00
Cash and bank deposits3 358.0057 045.0074 337.0087 974.00
Cash and cash equivalents3 358.00133 468.0088 255.00185 485.00
Balance sheet total (assets)4 730.00139 475.0096 902.00195 363.00

Equity and liabilities (kUSD)

2022
2023
2024
2025
Share capital26.00104.00104.00196.00
Share premium account186 163.00
Other reserves28 133.00
Retained earnings-5 894.00-27 288.00136 462.00244 579.00
Profit of the financial year-21 238.00-22 783.00-48 212.00-61 353.00
Shareholders equity total1 027.00136 196.0088 354.00183 422.00
Non-current leasing loans167.001 957.001 345.00
Non-current other liabilities-19.00
Non-current deferred tax liabilities19.0017.00
Non-current liabilities total167.001 974.001 345.00
Current trade creditors2 951.002 299.004 267.006 960.00
Other non-interest bearing current liabilities752.00813.002 307.003 636.00
Current liabilities total3 703.003 112.006 574.0010 596.00
Balance sheet total (liabilities)4 730.00139 475.0096 902.00195 363.00
Page generated